|
⚲
|
| Keyboard |
| Atlas Venture Fund IX LP
✚
|
|
|---|---|
| CIK # | 0001671219 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001671219] | |
| 4 | [0001671219] | |
| SC 13D | [0001671219] | |
| SC 13G | [0001671219] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Surface Oncology Inc SURF
Common Stock
|
2020-12-17 | Sell | 1,700,000 | $18.10 | 30,770,000 |
|
Surface Oncology Inc SURF
Series A Preferred Stock · derivative
|
2018-04-23 | Conversion | 7,000,000 | ||
|
Surface Oncology Inc SURF
Common Stock
|
2018-04-23 | Conversion | 3,181,817 | ||
|
Surface Oncology Inc SURF
Common Stock
|
2018-04-23 | Buy | 100,000 | $15.00 | 1,500,000 |
|
Cogent Biosciences Inc UMRX
Series B Preferred Stock · derivative
|
2018-04-03 | Conversion | 83,037 | $0.00 | |
|
Cogent Biosciences Inc UMRX
Common Stock
|
2018-04-03 | Conversion | 3,184,446 | ||
|
Cogent Biosciences Inc UMRX
Common Stock
|
2018-04-03 | Conversion | 83,037 | ||
|
Cogent Biosciences Inc UMRX
Common Stock
|
2018-04-03 | Buy | 94,052 | $12.00 | 1,128,624 |
|
Cogent Biosciences Inc UMRX
Series A Preferred Stock · derivative
|
2018-04-03 | Conversion | 3,184,446 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2017-07-11 | Sell | 80,000 | $16.07 | 1,285,600 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2017-07-10 | Sell | 40,000 | $16.17 | 646,800 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2017-07-07 | Sell | 30,000 | $16.77 | 503,100 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2017-03-03 | Other | 700,000 | ||
|
Intellia Therapeutics Inc NTLA
Founder Stock · derivative
|
2016-05-11 | Conversion | 946,237 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Series B Preferred Stock · derivative
|
2016-05-11 | Conversion | 761,905 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2016-05-11 | Conversion | 2,463,201 | ||
|
Intellia Therapeutics Inc NTLA
Series A-1 Preferred Stock · derivative
|
2016-05-11 | Conversion | 3,809,524 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Series A-2 Preferred Stock · derivative
|
2016-05-11 | Conversion | 1,333,333 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2016-05-11 | Conversion | 492,640 | ||
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2016-05-11 | Conversion | 611,827 | ||
| showing 20 of 21 most recent transactions | |||||